<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">74638</article-id><article-id pub-id-type="doi">10.7554/eLife.74638</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Novel protein markers of androgen activity in humans: proteomic study of plasma from young chemically castrated men</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-256666"><name><surname>Giwercman</surname><given-names>Aleksander</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5816-0785</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-260471"><name><surname>Sahlin</surname><given-names>K Barbara</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-260472"><name><surname>Pla Parada</surname><given-names>Indira</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-259750"><name><surname>Pawlowski</surname><given-names>Krzysztof</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5367-0935</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-260473"><name><surname>Fehninger</surname><given-names>Carl</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0922-7749</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-260474"><name><surname>Lundberg Giwercman</surname><given-names>Yvonne</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-260475"><name><surname>Leijonhufvud</surname><given-names>Irene</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-260476"><name><surname>Appelqvist</surname><given-names>Roger</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135199"><name><surname>Marko-Varga</surname><given-names>György</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-260477"><name><surname>Sanchez</surname><given-names>Aniel</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-260479"><name><surname>Malm</surname><given-names>Johan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Translational Medicine</institution>, <institution>Lund University</institution>, <addr-line><named-content content-type="city">Malmo</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff2"><institution content-type="dept">Department of Biomedical Engineering</institution>, <institution>Lund University</institution>, <addr-line><named-content content-type="city">Lund</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff3"><institution content-type="dept">Department of Experimental Design and Bioinformatics</institution>, <institution>Warsaw University of Life Sciences</institution>, <addr-line><named-content content-type="city">Warszawa</named-content></addr-line>, <country>Poland</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-63658"><name><surname>Sharifi</surname><given-names>Nima</given-names></name><role>Reviewing editor</role><aff><institution>Cleveland Clinic</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>aleksander.giwercman@med.lu.se</email> (AG);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>01</day><month>03</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e74638</elocation-id><history><date date-type="received"><day>12</day><month>10</month><year>2021</year></date><date date-type="accepted"><day>28</day><month>02</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Giwercman et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Giwercman et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-74638-v1.pdf"/><abstract><sec><title>Background:</title><p>Reliable biomarkers of androgen activity in humans are lacking. The aim of this study was, therefore, to identify new protein markers of biological androgen activity and test their predictive value in relation to low vs. normal testosterone values and some androgen deficiency linked pathologies.</p></sec><sec><title>Methods:</title><p>Blood samples from 30 healthy GnRH-antagonist treated males were collected at three time points: a) before GnRH antagonist administration; b) 3 weeks later, just before testosterone undecanoate injection, and c) after additional 2 weeks. Subsequently they were analysed by mass spectrometry to identify potential protein biomarkers of testosterone activity. Levels of proteins most significantly associated with testosterone fluctuations were further tested in a cohort of 75 hypo- and eugonadal males suffering from infertility. Associations between levels of those markers and cardio-metabolic parameters, bone mineral density as well as androgen receptor CAG repeat lengths, were explored.</p></sec><sec><title>Results:</title><p>Using ROC analysis, 4-hydroxyphenylpyruvate dioxygenase (4HPPD), insulin-like growth factor-binding protein 6 (IGFBP6) and fructose-bisphosphate aldolase (ALDOB), as well as a Multi Marker Algorithm, based on levels of 4HPPD and IGFBP6, were shown to be best predictors of low (&lt; 8 nmol/L) vs. normal (&gt; 12 nmol/L) testosterone. They were also more strongly associated with metabolic syndrome and diabetes than testosterone levels. Levels of ALDOB and 4HPPD levels also showed association with AR CAG-repeat lengths.</p></sec><sec><title>Conclusions:</title><p>We identified potential new protein biomarkers of testosterone action. Further investigations to elucidate their clinical potential are warranted.</p></sec><sec><title>Funding:</title><p>The work was supported by ReproUnion 2.0 (grant no 20201846), which is funded by the Interreg V EU program.</p></sec></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>ReproUnion</institution></institution-wrap></funding-source><award-id>20201846</award-id><principal-award-recipient><name><surname>Giwercman</surname><given-names>Aleksander</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Swedish Governmental Fund for Clinical Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Giwercman</surname><given-names>Aleksander</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Aleksander Giwercman, received consulting fees from Besins Healthcare. The author has no other competing interests to declare..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: All subjects were enrolled with informed written consent. The two studies from which they were recruited were approved by the Swedish Ethical Review Authority (Approval number: DNR 2014/311, date of approval 8 May 2014; DNR 2011/1, date of approval 11 January 2011).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (60) partner repository with the dataset identifier PXD024448.Supplementary tables (datasets):https://doi.org/10.6084/m9.figshare.14875431Source data of the Figures can be found on:https://doi.org/10.6084/m9.figshare.14875431Supplementary Figure S1 (Figure 2-figure supplement 1):https://doi.org/10.6084/m9.figshare.14876562</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Giwercman Aleksander</collab><collab>Sahlin K Barbara</collab><collab>Pla Indira</collab><collab>Pawlowski Krzysztof</collab><collab>Lundberg Giwercman Yvonne</collab><collab>Leijonhufvud Irene</collab><collab>et al</collab></person-group><year iso-8601-date="2021">2021</year><source>Supplementary tables, Novel protein markers of androgen activity in humans with potential clinical value</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.14875431.v2">https://doi.org/10.6084/m9.figshare.14875431.v2</ext-link><comment>doi.org/10.6084/m9.figshare.14875431.v2</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Giwercman Aleksander</collab><collab>Sahlin K Barbara</collab><collab>Pla Indira</collab><collab>Pawlowski Krzysztof</collab><collab>Lundberg Giwercman Yvonne</collab><collab>Leijonhufvud Irene</collab><collab>et al</collab></person-group><year iso-8601-date="2021">2021</year><source>Supplementary Figure S1, Novel protein markers of androgen activity in humans with potential clinical value.</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.14876562.v1">https://doi.org/10.6084/m9.figshare.14876562.v1</ext-link><comment>doi.org/10.6084/m9.figshare.14876562.v1</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Giwercman Aleksander</collab><collab>Sahlin K Barbara</collab><collab>Pla Indira</collab><collab>Pawlowski Krzysztof</collab><collab>Lundberg Giwercman Yvonne</collab><collab>Leijonhufvud Irene</collab><collab>et al</collab></person-group><year iso-8601-date="2022">2022</year><source>mass spectrometry proteomics data</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD024448">https://www.ebi.ac.uk/pride/archive/projects/PXD024448</ext-link><comment>PRIDE, PXD024448</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-74638-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>